Spyre Therapeutics Stock Forecast - Price Action Indicator
| SYRE Stock | 28.43 0.68 2.45% |
Spyre Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Spyre Therapeutics stock prices and determine the direction of Spyre Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Spyre Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Spyre |
| Check Spyre Therapeutics Volatility | Backtest Spyre Therapeutics | Information Ratio |
Spyre Therapeutics Trading Date Momentum
| On December 02 2024 Spyre Therapeutics was traded for 28.43 at the closing time. The top price for the day was 28.55 and the lowest listed price was 27.78 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 2.29% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Spyre Therapeutics to competition |
Other Forecasting Options for Spyre Therapeutics
For every potential investor in Spyre, whether a beginner or expert, Spyre Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Spyre Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Spyre. Basic forecasting techniques help filter out the noise by identifying Spyre Therapeutics' price trends.Spyre Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spyre Therapeutics stock to make a market-neutral strategy. Peer analysis of Spyre Therapeutics could also be used in its relative valuation, which is a method of valuing Spyre Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Spyre Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Spyre Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Spyre Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Spyre Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Spyre Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spyre Therapeutics shares will generate the highest return on investment. By undertsting and applying Spyre Therapeutics stock market strength indicators, traders can identify Spyre Therapeutics entry and exit signals to maximize returns.
Spyre Therapeutics Risk Indicators
The analysis of Spyre Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Spyre Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting spyre stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.84 | |||
| Semi Deviation | 3.94 | |||
| Standard Deviation | 3.64 | |||
| Variance | 13.23 | |||
| Downside Variance | 17.25 | |||
| Semi Variance | 15.49 | |||
| Expected Short fall | (2.76) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Spyre Therapeutics is a strong investment it is important to analyze Spyre Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Spyre Therapeutics' future performance. For an informed investment choice regarding Spyre Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Spyre Therapeutics to cross-verify your projections. For information on how to trade Spyre Stock refer to our How to Trade Spyre Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spyre Therapeutics. If investors know Spyre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spyre Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (37.90) | Return On Assets (0.39) | Return On Equity (0.92) |
The market value of Spyre Therapeutics is measured differently than its book value, which is the value of Spyre that is recorded on the company's balance sheet. Investors also form their own opinion of Spyre Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spyre Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spyre Therapeutics' market value can be influenced by many factors that don't directly affect Spyre Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spyre Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.